New mTOR Inhibitors
| Cat.No. | Product Name | Information |
|---|---|---|
| S8738 | Bimiralisib (PQR309) | Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTOR inhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets. |
| ≡ All mTOR Inhibitors | ||
